Form 4 for STLN Starling Oncology, Inc.
Accepted 2025-07-24 00:00:00 ET · period of report 2025-07-22 · accession 0000935836-25-000470 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-24 | 2025-07-22 | STLN | England Kristin | Chief Administrative Off | A - Grant | $0.00 | +98.0K | 98.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-22 | A | A | 98,037 | $0.00 | 98,037 | D | — | — | (F1) Represents RSU awards that were fully vested upon grant, net of withholding tax obligations |